Wells Fargo analyst Larry Biegelsen downgrades Edwards Lifesciences (NYSE:EW) from Overweight to Equal-Weight and lowers the price target from $97 to $78.
Keefe, Bruyette & Woods analyst Jade Rahmani downgrades Ares Comml Real Est (NYSE:ACRE) from Outperform to Market Perform and announces $12.5 price target.
Raymond James has downgraded Gossamer Bio Inc (NASDAQ:GOSS) to Market Perform from Outperform following the publication of sotatercept’s Phase 3 data in NEJM. …
RBC Capital analyst Keith Mackey downgrades Secure Energy Services (TSX:SES) from Outperform to Sector Perform and lowers the price target from C$11 to C$8.